Supplementary Materials and Methods from In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2–CDK4/6 Targeting and mTOR–S6 Resistance Mechanisms

Authors :: Andrew E. Aplin
Reinhard Dummer
Mitch P. Levesque
Lawrence N. Kwong
Michael A. Davies
Kim HooKim
Ines Kleiber
Paolo M. Fortina
Adam Ertel
Inna Chervoneva
Prem Patel
Neda Nikbakht
Timothy J. Purwin
Phil F. Cheng
Jessica L.F. Teh
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Materials and Methods

Tools